Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Palisade Bio (PALI) over the last 11 years, with Q3 2025 value amounting to $0.07.

  • Palisade Bio's Debt to Equity changed N/A to $0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.07, marking a year-over-year change of. This contributed to the annual value of $0.01 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Palisade Bio's Debt to Equity is $0.07.
  • Over the past 5 years, Palisade Bio's Debt to Equity peaked at $0.07 during Q3 2025, and registered a low of -$0.12 during Q2 2021.
  • Moreover, its 4-year median value for Debt to Equity was $0.01 (2024), whereas its average is $0.0.
  • Within the past 5 years, the most significant YoY rise in Palisade Bio's Debt to Equity was 6820.38% (2025), while the steepest drop was 890.91% (2025).
  • Palisade Bio's Debt to Equity (Quarter) stood at -$0.12 in 2021, then soared by 110.46% to $0.01 in 2023, then grew by 18.48% to $0.01 in 2024, then surged by 388.52% to $0.07 in 2025.
  • Its last three reported values are $0.07 in Q3 2025, $0.03 for Q2 2025, and $0.01 during Q1 2025.